A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia
Section snippets
Acknowledgements
The authors are grateful to the Zikei Institute of Psychiatry (Okayama, Japan), the Ministry of Health, Labour and Welfare of Japan, and the Ministry of Education, Culture, Sports, Science and Technology of Japan for support in part by grants.
References (40)
- et al.
Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use
Neuroscience
(2001) - et al.
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine
Brain Res.
(2002) - et al.
Chronic treatment with delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction
Neuropharmacology
(2001) - et al.
Cannabis and acute psychosis
Schizophr. Res.
(1994) - et al.
Behavioral sensitization to amphetamine follows chronic administration of the CB1 agonist WIN 55,212-2 in Lewis rats
Pharmacol. Biochem. Behav.
(2002) - et al.
Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice
Neuropharmacology
(2004) - et al.
N-Acylated glycerophospholipids and their derivatives
Prog. Lipid. Res.
(1990) - et al.
Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice
Brain Res.
(2001) - et al.
Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia
Prog. Neuropsychopharmacol. Biol. Psychiatry
(2004) - et al.
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
Br. Med. J.
(2002)
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
Proc. Natl. Acad. Sci. U.S.A.
(2001)
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Nature
(1996)
Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system
Curr. Opin. Chem. Biol.
(2003)
Chemical characterization of a family of brain lipids that induce sleep
Science
(1995)
Determination and characterization of a cannabinoid receptor in rat brain
Mol. Pharmacol.
(1988)
Isolation and structure of a brain constituent that binds to the cannabinoid receptor
Science
(1992)
Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats
J. Neurochem.
(2000)
Molecular characterization of human and mouse fatty acid amide hydrolases
Proc. Natl. Acad. Sci. U.S.A.
(1997)
Marihuana use and psychiatric illness
Arch. Gen. Psychiatry
(1972)
Psychiatric effects of cannabis
Br. J. Psychiatry
(2001)
Cited by (0)
Copyright © 2004 Elsevier Ireland Ltd. All rights reserved.